Transitioning from wild collection to forest cultivation of indigenous medicinal forest plants in eastern North America

Paper presented at the 11th North American Agroforesty Conference, which was held May 31-June 3, 2009 in Columbia, Missouri.In Gold, M.A. and M.M. Hall, eds. Agroforestry Comes of Age: Putting Science into Practice. Proceedings, 11th North American Agroforestry Conference, Columbia, Mo., May 31-June 3, 2009.The forest flora of eastern North America includes many herbaceous plant species traded in domestic and international medicinal markets. Conservation concerns surrounding wild-collection exist and transitioning to cultivation in agroforestry systems has potential economic and ecological benefits. Costs and revenues associated with adopting forest cultivation were modeled for eight North American medicinal forest plants. Sensitivity analysis examined profit potential in relation to (1) discount rates; (2) propagation methods; (3) prices; (4) growing period; (5) production costs; and (6) yields. Results indicate that intensive husbandry of six of eight species would be unprofitable at recent (1990-2005) price levels. Exceptions are American ginseng (Panax quinquefolius L.), and under certain circumstances (e.g., maximum historic prices, low production costs) goldenseal (Hydrastis canadensis L.). Direct marketing to consumers and retailers might improve grower profits, but is undermined by the availability of cheaper, wild-collected product. We suggest that the North American medicinal plant industry could play a key role in facilitating any transition from wild to cultivated product, perhaps through development of a certification and labeling program that brands "forest cultivated" products. This could generate price premiums, to be passed along to growers, but must be accompanied by aggressive consumer education. A "forest cultivated" certification and labeling program has potential to benefit industry and consumers if assurances regarding product identity and quality are a central feature. Plant species that are not viable candidates for commercial cultivation due to limited consumer demand (i.e., species with "shallow," erratic markets) are best addressed through proactive government and industry initiatives involving targeted harvester education programs.Eric P. Burkhart (1) and Michael G. Jacobson (2) ; 1. Shaver's Creek Environmental Center, the Pennsylvania State University, Petersburg, PA 16669, USA. 2. School of Forest Resources, the Pennsylvania State University, University Park, PA 16802, USA.Includes bibliographical references

Cloud structure of three Galactic infrared dark star-forming regions from combining ground and space based bolometric observations

We have modified the iterative procedure introduced by Lin et al. (2016), to systematically combine the submm images taken from ground based (e.g., CSO, JCMT, APEX) and space (e.g., Herschel, Planck) telescopes. We applied the updated procedure to observations of three well studied Infrared Dark Clouds (IRDCs): G11.11-0.12, G14.225-0.506 and G28.34+0.06, and then performed single-component, modified black-body fits to derive $\sim$10$"$ resolution dust temperature and column density maps. The derived column density maps show that these three IRDCs exhibit complex filamentary structures embedding with rich clumps/cores. We compared the column density probability distribution functions (N-PDFs) and two-point correlation (2PT) functions of the column density field between these IRDCs with several OB cluster-forming regions. Based on the observed correlation and measurements, and complementary hydrodynamical simulations for a 10$^{4}$ $\rm M_{\odot}$ molecular cloud, we hypothesize that cloud evolution can be better characterized by the evolution of the (column) density distribution function and the relative power of dense structures as a function of spatial scales, rather than merely based on the presence of star-forming activity. Based on the small analyzed sample, we propose four evolutionary stages, namely: {\it cloud integration, stellar assembly, cloud pre-dispersal and dispersed-cloud.} The initial {\it cloud integration} stage and the final {\it dispersed cloud} stage may be distinguished from the two intermediate stages by a steeper than $-$4 power-law index of the N-PDF. The {\it cloud integration} stage and the subsequent {\it stellar assembly} stage are further distinguished from each other by the larger luminosity-to-mass ratio ($>$40 $\rm L_{\odot}/M_{\odot}$) of the latter

Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling

Human cancers often contain genetic alterations that disable G1/S checkpoint control and loss of this checkpoint is thought to critically contribute to cancer generation by permitting inappropriate proliferation and distorting fate-driven cell cycle exit. The identification of cell permeable small molecules that activate the G1/S checkpoint may therefore represent a broadly applicable and clinically effective strategy for the treatment of cancer. Here we describe the identification of several novel small molecules that trigger G1/S checkpoint activation and characterise the mechanism of action for one, CCT020312, in detail. Transcriptional profiling by cDNA microarray combined with reverse genetics revealed phosphorylation of the eukaryotic initiation factor 2-alpha (EIF2A) through the eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3/PERK) as the mechanism of action of this compound. While EIF2AK3/PERK activation classically follows endoplasmic reticulum (ER) stress signalling that sets off a range of different cellular responses, CCT020312 does not trigger these other cellular responses but instead selectively elicits EIF2AK3/PERK signalling. Phosphorylation of EIF2A by EIF2A kinases is a known means to block protein translation and hence restriction point transit in G1, but further supports apoptosis in specific contexts. Significantly, EIF2AK3/PERK signalling has previously been linked to the resistance of cancer cells to multiple anticancer chemotherapeutic agents, including drugs that target the ubiquitin/proteasome pathway and taxanes. Consistent with such findings CCT020312 sensitizes cancer cells with defective taxane-induced EIF2A phosphorylation to paclitaxel treatment. Our work therefore identifies CCT020312 as a novel small molecule chemical tool for the selective activation of EIF2A-mediated translation control with utility for proof-of-concept applications in EIF2A-centered therapeutic approaches, and as a chemical starting point for pathway selective agent development. We demonstrate that consistent with its mode of action CCT020312 is capable of delivering potent, and EIF2AK3 selective, proliferation control and can act as a sensitizer to chemotherapy-associated stresses as elicited by taxanes

Antibody Responses against Xenotropic Murine Leukemia Virus-Related Virus Envelope in a Murine Model

Xenotropic murine leukemia virus-related virus (XMRV) was recently discovered to be the first human gammaretrovirus that is associated with chronic fatigue syndrome and prostate cancer (PC). Although a mechanism for XMRV carcinogenesis is yet to be established, this virus belongs to the family of gammaretroviruses well known for their ability to induce cancer in the infected hosts. Since its original identification XMRV has been detected in several independent investigations; however, at this time significant controversy remains regarding reports of XMRV detection/prevalence in other cohorts and cell type/tissue distribution. The potential risk of human infection, coupled with the lack of knowledge about the basic biology of XMRV, warrants further research, including investigation of adaptive immune responses. To study immunogenicity in vivo, we vaccinated mice with a combination of recombinant vectors expressing codon-optimized sequences of XMRV gag and env genes and virus-like particles (VLP) that had the size and morphology of live infectious XMRV.Immunization elicited Env-specific binding and neutralizing antibodies (NAb) against XMRV in mice. The peak titers for ELISA-binding antibodies and NAb were 1:1024 and 1:464, respectively; however, high ELISA-binding and NAb titers were not sustained and persisted for less than three weeks after immunizations.Vaccine-induced XMRV Env antibody titers were transiently high, but their duration was short. The relatively rapid diminution in antibody levels may in part explain the differing prevalences reported for XMRV in various prostate cancer and chronic fatigue syndrome cohorts. The low level of immunogenicity observed in the present study may be characteristic of a natural XMRV infection in humans

Synchronous volcanic eruptions and abrupt climate change ∼17.7 ka plausibly linked by stratospheric ozone depletion.

Glacial-state greenhouse gas concentrations and Southern Hemisphere climate conditions persisted until ∼17.7 ka, when a nearly synchronous acceleration in deglaciation was recorded in paleoclimate proxies in large parts of the Southern Hemisphere, with many changes ascribed to a sudden poleward shift in the Southern Hemisphere westerlies and subsequent climate impacts. We used high-resolution chemical measurements in the West Antarctic Ice Sheet Divide, Byrd, and other ice cores to document a unique, ∼192-y series of halogen-rich volcanic eruptions exactly at the start of accelerated deglaciation, with tephra identifying the nearby Mount Takahe volcano as the source. Extensive fallout from these massive eruptions has been found >2,800 km from Mount Takahe. Sulfur isotope anomalies and marked decreases in ice core bromine consistent with increased surface UV radiation indicate that the eruptions led to stratospheric ozone depletion. Rather than a highly improbable coincidence, circulation and climate changes extending from the Antarctic Peninsula to the subtropics-similar to those associated with modern stratospheric ozone depletion over Antarctica-plausibly link the Mount Takahe eruptions to the onset of accelerated Southern Hemisphere deglaciation ∼17.7 ka

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling.

Human cancers often contain genetic alterations that disable G1/S checkpoint control and loss of this checkpoint is thought to critically contribute to cancer generation by permitting inappropriate proliferation and distorting fate-driven cell cycle exit. The identification of cell permeable small molecules that activate the G1/S checkpoint may therefore represent a broadly applicable and clinically effective strategy for the treatment of cancer. Here we describe the identification of several novel small molecules that trigger G1/S checkpoint activation and characterise the mechanism of action for one, CCT020312, in detail. Transcriptional profiling by cDNA microarray combined with reverse genetics revealed phosphorylation of the eukaryotic initiation factor 2-alpha (EIF2A) through the eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3/PERK) as the mechanism of action of this compound. While EIF2AK3/PERK activation classically follows endoplasmic reticulum (ER) stress signalling that sets off a range of different cellular responses, CCT020312 does not trigger these other cellular responses but instead selectively elicits EIF2AK3/PERK signalling. Phosphorylation of EIF2A by EIF2A kinases is a known means to block protein translation and hence restriction point transit in G1, but further supports apoptosis in specific contexts. Significantly, EIF2AK3/PERK signalling has previously been linked to the resistance of cancer cells to multiple anticancer chemotherapeutic agents, including drugs that target the ubiquitin/proteasome pathway and taxanes. Consistent with such findings CCT020312 sensitizes cancer cells with defective taxane-induced EIF2A phosphorylation to paclitaxel treatment. Our work therefore identifies CCT020312 as a novel small molecule chemical tool for the selective activation of EIF2A-mediated translation control with utility for proof-of-concept applications in EIF2A-centered therapeutic approaches, and as a chemical starting point for pathway selective agent development. We demonstrate that consistent with its mode of action CCT020312 is capable of delivering potent, and EIF2AK3 selective, proliferation control and can act as a sensitizer to chemotherapy-associated stresses as elicited by taxanes

Cloud Structure of Galactic OB Cluster Forming Regions from Combining Ground and Space Based Bolometric Observations

We have developed an iterative procedure to systematically combine the millimeter and submillimeter images of OB cluster-forming molecular clouds, which were taken by ground based (CSO, JCMT, APEX, IRAM-30m) and space telescopes (Herschel, Planck). For the seven luminous ($L$$>$10$^{6}$ $L_{\odot}$) Galactic OB cluster-forming molecular clouds selected for our analyses, namely W49A, W43-Main, W43-South, W33, G10.6-0.4, G10.2-0.3, G10.3-0.1, we have performed single-component, modified black-body fits to each pixel of the combined (sub)millimeter images, and the Herschel PACS and SPIRE images at shorter wavelengths. The $\sim$10$"$ resolution dust column density and temperature maps of these sources revealed dramatically different morphologies, indicating very different modes of OB cluster-formation, or parent molecular cloud structures in different evolutionary stages. The molecular clouds W49A, W33, and G10.6-0.4 show centrally concentrated massive molecular clumps that are connected with approximately radially orientated molecular gas filaments. The W43-Main and W43-South molecular cloud complexes, which are located at the intersection of the Galactic near 3-kpc (or Scutum) arm and the Galactic bar, show a widely scattered distribution of dense molecular clumps/cores over the observed $\sim$10 pc spatial scale. The relatively evolved sources G10.2-0.3 and G10.3-0.1 appear to be affected by stellar feedback, and show a complicated cloud morphology embedded with abundant dense molecular clumps/cores. We find that with the high angular resolution we achieved, our visual classification of cloud morphology can be linked to the systematically derived statistical quantities (i.e., the enclosed mass profile, the column density probability distribution function, the two-point correlation function of column density, and the probability distribution function of clump/core separations)

CMB-S4

We describe the stage 4 cosmic microwave background ground-based experiment CMB-S4

American ginseng (Panax quinquefolius L.) floristic associations in Pennsylvania: guidance for identifying calcium-rich forest farming sites

Abstract In the eastern United States, there is interest among forest landowners in American ginseng husbandry, and particularly in cultivating this plant on forestlands using a wild-simulated forest farming approach. This study documented the flora and soil conditions associated with wild and wild-simulated ginseng populations throughout Pennsylvania (PA) to develop floristic ''indicators'' that can be used to identify supportive growing sites on forestlands. A total of 243 plant species were documented associates of ginseng across PA: 32 over-story trees, 37 shrubs and understory trees, 15 vines, 143 herbs, and 16 ferns. Statistical analysis revealed a largely shared floristic assemblage throughout the state although some associates did differ according to region and physiographic province. Previous studies have suggested that a soil calcium content, especially soils having at least 3,360 kg ha -1 (3,000 lbs ac), appear to be particularly conducive to wild and wild-simulated ginseng occurrence and/or vigor, and indicator species analysis in this study revealed that three of the top plant associates that can be used for determining sites that meet this calcium threshold in PA are white ash, Jack-in-thepulpit, and rattlesnake fern. These results suggest that successful adoption of wild-simulated ginseng forest farming is likely to be improved in forested areas where these species are found collectively as a dominant component of local plant assemblages